Their Chinese Phase 1 reportedly showed motor improvement in 90% of patients. With that data in hand, the FDA is allowing them to move forward out West.
Researchers are testing a minimally invasive stem cell patch that could reduce the need for transplants.
For decades, treating diseases of the central nervous system (CNS) with stem cells has been hampered by one persistent biological obstacle: the blood–brain barrier (BBB). While the BBB protects the brain from harmful substances, it also blocks most drugs and…
Researchers may now have a new tool to unlock insights into blood-brain barrier regulation and neurological disease mechanisms.